HRP20010764B1 - Oralna otopina s prukalopridom - Google Patents

Oralna otopina s prukalopridom

Info

Publication number
HRP20010764B1
HRP20010764B1 HR20010764A HRP20010764A HRP20010764B1 HR P20010764 B1 HRP20010764 B1 HR P20010764B1 HR 20010764 A HR20010764 A HR 20010764A HR P20010764 A HRP20010764 A HR P20010764A HR P20010764 B1 HRP20010764 B1 HR P20010764B1
Authority
HR
Croatia
Prior art keywords
oral solution
prucalopride
prucalopride oral
methoxypropyl
benzofuran
Prior art date
Application number
HR20010764A
Other languages
English (en)
Inventor
Andre Eddy
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of HRP20010764A2 publication Critical patent/HRP20010764A2/hr
Publication of HRP20010764B1 publication Critical patent/HRP20010764B1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Abstract

Oralna vodena otopina, naznacena time, da ima pH u rasponu od 2 do 5 i da sadrzi aktivni sastojak 4-amino-5-klor-2,3-dihidro-N-[1-(3-metoksipropil)-4-piperidinil]-7-benzofuran-karboksamid, ili njegovu farmaceutski prihvatljivu kiselinsku adicijsku sol te da nadalje sadrzi benzojevu kiselinu. Patent sadrzi jos 7 patentnih zahtjeva.
HR20010764A 1999-04-29 2001-10-19 Oralna otopina s prukalopridom HRP20010764B1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99201335 1999-04-29
PCT/EP2000/003739 WO2000066170A1 (en) 1999-04-29 2000-04-20 Prucalopride oral solution

Publications (2)

Publication Number Publication Date
HRP20010764A2 HRP20010764A2 (en) 2002-12-31
HRP20010764B1 true HRP20010764B1 (hr) 2011-01-31

Family

ID=8240160

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20010764A HRP20010764B1 (hr) 1999-04-29 2001-10-19 Oralna otopina s prukalopridom

Country Status (36)

Country Link
US (1) US6413988B1 (hr)
EP (1) EP1176982B1 (hr)
JP (1) JP4773619B2 (hr)
KR (1) KR100669175B1 (hr)
CN (1) CN1165345C (hr)
AR (1) AR023815A1 (hr)
AT (1) ATE254929T1 (hr)
AU (1) AU770073B2 (hr)
BG (1) BG65061B1 (hr)
BR (1) BRPI0010150B8 (hr)
CA (1) CA2371178C (hr)
CZ (1) CZ294070B6 (hr)
DE (1) DE60006799T2 (hr)
DK (1) DK1176982T3 (hr)
EA (1) EA003904B1 (hr)
EE (1) EE05264B1 (hr)
ES (1) ES2211546T3 (hr)
HK (1) HK1045950B (hr)
HR (1) HRP20010764B1 (hr)
HU (1) HU228924B1 (hr)
ID (1) ID30397A (hr)
IL (2) IL146152A0 (hr)
JO (1) JO2181B1 (hr)
MX (1) MXPA01010953A (hr)
MY (1) MY119880A (hr)
NO (1) NO331448B1 (hr)
NZ (1) NZ515119A (hr)
PL (1) PL195674B1 (hr)
PT (1) PT1176982E (hr)
SI (1) SI1176982T1 (hr)
SK (1) SK284847B6 (hr)
TR (1) TR200103121T2 (hr)
TW (1) TW592709B (hr)
UA (1) UA68426C2 (hr)
WO (1) WO2000066170A1 (hr)
ZA (1) ZA200108820B (hr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050063998A1 (en) * 1999-10-26 2005-03-24 Francois Marc Karel Jozef Oral solution containing galantamine and a sweetening agent
US20040096423A1 (en) * 2000-11-24 2004-05-20 Megens Antonius Adrianus Hendrikus Petrus Use of a triple combination comprising a 5ht3 antagonist, a 5ht4agonist and a laxative for promoting intestinal lavage
DE60300683T2 (de) 2002-01-16 2006-04-27 Janssen Pharmaceutica N.V. Prucaloprid-n-oxid
JP4526247B2 (ja) * 2002-07-08 2010-08-18 第一三共株式会社 経口用セファロスポリン製剤
FI20022007A0 (fi) * 2002-11-08 2002-11-08 Juvantia Pharma Ltd Oy Oromukosaalinen valmiste ja menetelmä sen valmistamiseksi
ES2388501T3 (es) 2004-08-12 2012-10-16 Helsinn Healthcare S.A. Uso de secretagogos de la hormona de crecimiento para estimular la motilidad del sistema gastrointestinal
GB201103397D0 (hr) 2011-02-28 2011-04-13 Shire Movetis N V
US8568747B1 (en) 2012-10-05 2013-10-29 Silvergate Pharmaceuticals, Inc. Enalapril compositions
US9463183B1 (en) 2015-10-30 2016-10-11 Silvergate Pharmaceuticals, Inc. Lisinopril formulations
US9669008B1 (en) 2016-03-18 2017-06-06 Silvergate Pharmaceuticals, Inc. Enalapril formulations

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0389037A1 (en) * 1989-03-22 1990-09-26 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
EP0445862A2 (en) * 1990-03-06 1991-09-11 Janssen Pharmaceutica N.V. N-(4-piperidinyl)(dihydrobenzofuran or dihydro-2H-benzopyran)carboxamide derivatives
WO1996016060A1 (en) * 1994-11-24 1996-05-30 Janssen Pharmaceutica N.V. Enterokinetic benzamide
WO2000030640A1 (en) * 1998-11-23 2000-06-02 Janssen Pharmaceutica N.V. Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05163154A (ja) * 1991-12-13 1993-06-29 Kanebo Ltd 経口液剤

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0389037A1 (en) * 1989-03-22 1990-09-26 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
EP0445862A2 (en) * 1990-03-06 1991-09-11 Janssen Pharmaceutica N.V. N-(4-piperidinyl)(dihydrobenzofuran or dihydro-2H-benzopyran)carboxamide derivatives
WO1996016060A1 (en) * 1994-11-24 1996-05-30 Janssen Pharmaceutica N.V. Enterokinetic benzamide
WO2000030640A1 (en) * 1998-11-23 2000-06-02 Janssen Pharmaceutica N.V. Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia

Also Published As

Publication number Publication date
CA2371178C (en) 2008-03-25
HUP0202324A2 (hu) 2002-12-28
EP1176982A1 (en) 2002-02-06
AR023815A1 (es) 2002-09-04
HK1045950B (zh) 2005-05-27
SK15192001A3 (sk) 2002-03-05
NO20014794L (no) 2001-10-02
US6413988B1 (en) 2002-07-02
KR100669175B1 (ko) 2007-01-17
CA2371178A1 (en) 2000-11-09
PT1176982E (pt) 2004-04-30
MY119880A (en) 2005-07-29
UA68426C2 (uk) 2004-08-16
WO2000066170A1 (en) 2000-11-09
SI1176982T1 (en) 2004-04-30
SK284847B6 (sk) 2006-01-05
DE60006799D1 (de) 2004-01-08
ID30397A (id) 2001-11-29
PL195674B1 (pl) 2007-10-31
BR0010150A (pt) 2002-01-15
AU770073B2 (en) 2004-02-12
NZ515119A (en) 2003-05-30
EP1176982B1 (en) 2003-11-26
AU4913700A (en) 2000-11-17
TR200103121T2 (tr) 2002-05-21
BG65061B1 (bg) 2007-01-31
JO2181B1 (en) 2003-04-23
HK1045950A1 (en) 2002-12-20
NO331448B1 (no) 2012-01-02
CN1348386A (zh) 2002-05-08
KR20020004972A (ko) 2002-01-16
DE60006799T2 (de) 2004-09-23
IL146152A (en) 2006-12-31
BRPI0010150B1 (pt) 2015-06-23
HUP0202324A3 (en) 2003-03-28
HU228924B1 (en) 2013-06-28
ZA200108820B (en) 2003-01-27
HRP20010764A2 (en) 2002-12-31
EE05264B1 (et) 2010-02-15
IL146152A0 (en) 2002-07-25
JP4773619B2 (ja) 2011-09-14
PL352062A1 (en) 2003-07-28
JP2002543161A (ja) 2002-12-17
TW592709B (en) 2004-06-21
MXPA01010953A (es) 2002-05-06
ATE254929T1 (de) 2003-12-15
CZ20013735A3 (cs) 2002-02-13
BG106031A (en) 2002-05-31
ES2211546T3 (es) 2004-07-16
DK1176982T3 (da) 2004-03-29
CN1165345C (zh) 2004-09-08
EA003904B1 (ru) 2003-10-30
CZ294070B6 (cs) 2004-09-15
BRPI0010150B8 (pt) 2021-05-25
EA200101150A1 (ru) 2002-04-25
EE200100539A (et) 2002-12-16
NO20014794D0 (no) 2001-10-02

Similar Documents

Publication Publication Date Title
FR2789079B3 (fr) Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant
TR200302105T4 (tr) Siklosporin, hiyalüronik asit ve polisorbat içeren göz formülasyonları.
HRP20020198B1 (hr) Formulacija moksifloksacina i kuhinjske soli
HRP20020880B1 (hr) Novi farmaceutski pripravak
MA26548A1 (fr) Compositions pharmaceutiques topiques contenant des derives de resorcinol.
RS49609B (sr) Stabilizovani antihistaminski sirup
DZ2964A1 (fr) Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant.
FR2805818B1 (fr) Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
DE60045528D1 (de) Pharmazeutische zusammensetzungen, die ccr5-antagonisierende piperazinderivate enthalten
FR2775596B1 (fr) Nouvelles compositions pharmaceutiques
EE05383B1 (et) Polarlkarboksamiidhendid,ÁnendeÁvalmistamineÁjaÁkasutamineÁlipiiditasetÁalandavateÁtoimeainetenaÁningÁneidÁsisaldavÁfarmatseutilineÁkompositsioon
MA26968A1 (fr) Compositions pharmaceutiques contenant du maleate d'amlodipine.
TNSN95076A1 (fr) Forme de dosage ii d'unite multiple en comprime
EE05157B1 (et) N-[(asendatud bensüül)-4-piperidinüüli v?i pürrolidinüül]aminohüdroksüalkoksüfenüülide derivaadid, meetod nende valmistamiseks ning nende kasutamine meditsiinis
ATE345133T1 (de) Laktose-freie, nicht-hygroskopische und wasserfreie pharmazeutische zusammensetzungen von descarboethoxyloratadin
MY130441A (en) Solutions containing epinastin
DK1104289T3 (da) Hidtil ukendte orale formuleringer for 5-HT4-agonister eller -antagonister
HRP20010764B1 (hr) Oralna otopina s prukalopridom
RS50089B (sr) Suspenzija ziprasidona
FR2792529B1 (fr) Nouvelles compositions pharmaceutiques comprenant des derives de 2-isoxazole-8-aminotetralines
SE0001916D0 (sv) Novel formulation
FR2779145B1 (fr) Nouvelles compositions pharmaceutiques
YU87501A (sh) Farmaceutski kompleksi
IT1306147B1 (it) Derivati di principi attivi ad attivita' terapeutica e/o nutrizionalee composizioni atte alla somministrazione orale contenenti tali
HRP20020332B1 (hr) Oralne otopine koje sadrže galantamin i sladilo

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20190320

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20200420